|Articles|November 1, 2003
Slow, Steady Tx Release
Author(s)Louise Gagnon
San Diego - The most current data from an open label trial show that hydroquinone 4 percent with retinol is an effective and safe option to treat melasma and post-inflammatory hyperpigmentation, according to Pearl Grimes, M.D., the study's principal investigator.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Phase 2 Nemolizumab Trial Opens for CPUO
3
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
4
Transformative Advances This Year and Beyond
5














